Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

JOHNSON & JOHNSON

(JNJ)
  Report
Real-time Estimate Cboe BZX  -  11:53 2022-12-07 am EST
176.83 USD   +0.41%
11:12aJohnson & Johnson : to Participate in the 41st Annual J.P. Morgan Healthcare Conference
PU
10:31aJohnson & Johnson - Tackling Health Disparities Through Empowerment, Partnership and Scholarship
AQ
04:38aGSK, Pfizer, Sanofi Breathe Sigh Of Relief After US Court Tosses Lawsuits On Zantac Cancer Link
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about JOHNSON & JOHNSON
11:12aJohnson & Johnson : to Participate in the 41st Annual J.P. Morgan Healthcare Conference
PU
10:31aJohnson & Johnson - Tackling Health Disparities Through Empowerment, Partnership and Sc..
AQ
12/06Morgan Stanley Trims Price Target on Johnson & Johnson to $176 From $178, Maintains Equ..
MT
12/05Johnson & Johnson : Announcement for the purposes of Rule 2.8 of the Irish Takeover Panel ..
PU
12/05Johnson & Johnson's Janssen Global Services Unit Says No Plans to Bid for Horizon Thera..
MT
12/03Johnson & Johnson : Announcement for the purposes of Rule 2.8 of the Irish Takeover Panel ..
PU
12/02Insider Sell: Johnson & Johnson
MT
12/01Morgan Stanley Adjusts Price Target on Johnson & Johnson to $178 From $170, Maintains E..
MT
11/30Johnson & Johnson Chief Executive Joaquin Duato to Also Assume Chairman Role
MT
11/30Johnson & Johnson CEO Joaquin Duato to Become Chairman of the Board
DJ
11/30Johnson & Johnson Names CEO Joaquin Duato as Chairman of the Board
BU
11/30Johnson & Johnson Names CEO Joaquin Duato as Chairman of the Board
CI
11/23Sector Update: Health Care Stocks Still Advancing in Wednesday Trading
MT
11/23Sector Update: Health Care
MT
11/23Johnson & Johnson's Janssen Pharmaceutical Says Phase 3 Trial of Major Depressive Disor..
MT
More most relevant news
All news about JOHNSON & JOHNSON
11:12aJohnson & Johnson : to Participate in the 41st Annual J.P. Morgan Healthcare Conference
PU
10:31aJohnson & Johnson - Tackling Health Disparities Through Empowerment, Partnership and Sc..
AQ
04:38aGSK, Pfizer, Sanofi Breathe Sigh Of Relief After US Court Tosses Lawsuits On Zantac Can..
MT
12/06Major Pharma Companies to Remain Defensive Through at least H1 2023 Amid M&As, New Prod..
MT
12/06Morgan Stanley Trims Price Target on Johnson & Johnson to $176 From $178, Maintains Equ..
MT
12/05Johnson & Johnson : Announcement for the purposes of Rule 2.8 of the Irish Takeover Panel ..
PU
12/05Yumanity Therapeutics to Pay Special Cash Dividend Related to Planned Asset Sale, Kinet..
MT
12/05Johnson & Johnson's Janssen Global Services Unit Says No Plans to Bid for Horizon Thera..
MT
12/03Johnson & Johnson : Announcement for the purposes of Rule 2.8 of the Irish Takeover Panel ..
PU
12/02Insider Sell: Johnson & Johnson
MT
More news
News in other languages on JOHNSON & JOHNSON
04:38aGSK, Pfizer et Sanofi poussent un soupir de soulagement après le rejet par un tribunal ..
12/06Selon Morgan Stanley, les principales sociétés pharmaceutiques resteront sur la défensi..
12/05Yumanity Therapeutics versera un dividende spécial en espèces lié à la vente d'actifs p..
12/05L'unité Janssen Global Services de Johnson & Johnson ne prévoit pas de faire une offre ..
12/05EN DIRECTO DESDE LOS MERCADOS: Amazon, Apple, Valneva, Bén..
12/05En Direct des Marchés : Renault, GTT, Valneva, Bénéteau, Vodafone,..
12/02Paris en léger recul pour finir la semaine
12/02Sanofi déclare que toute offre potentielle pour Horizon Therapeutics sera faite en espè..
12/02Paris baisse en attendant l'emploi américain
12/01Les valeurs à suivre aujourd'hui à Wall Street - Jeudi 1er décembre 2022
More news
Analyst Recommendations on JOHNSON & JOHNSON
12/06Morgan Stanley Trims Price Target on Johnson & Johnson to $176 From $178, Maintains Equ..
MT
12/01Morgan Stanley Adjusts Price Target on Johnson & Johnson to $178 From $170, Maintains E..
MT
11/18Credit Suisse Starts Johnson & Johnson at Neutral With $170 Price Target
MT
11/18Analyst recommendations: AbbVie, Bristol-Myers, Dominion Energy,..
MS
10/20Bernstein Adjusts Price Target on Johnson & Johnson to $190 From $194, Maintains Market..
MT
More recommendations
Press releases
11:12aJohnson & Johnson : to Participate in the 41st Annual J.P. Morgan Healthcare Conference
PU
10:31aJohnson & Johnson - Tackling Health Disparities Through Empowerment, Partnership and Sc..
AQ
12/05Johnson & Johnson : Announcement for the purposes of Rule 2.8 of the Irish Takeover Panel ..
PU
12/03Johnson & Johnson : Announcement for the purposes of Rule 2.8 of the Irish Takeover Panel ..
PU
12/01First Wave BioPharma Files IND For Enhanced Formulation Of Adrulipase; Topline Results ..
AQ
More press releases
Upcoming event on JOHNSON & JOHNSON